Jaffe SA, et al. - Utilizing data from 18 Surveillance, Epidemiology, and End Results Program cancer registries, researchers examined the link between insurance type at diagnosis and stage-specific survival in hepatocellular carcinoma (HCC) by performing this retrospective cohort study. Eligibility criteria for inclusion included cases with ages 20 to 64 years, a primary HCC diagnosis received between 2010 and 2015, with either private, Medicaid, or no insurance. There were 14,655 cases in total. A 43%, 22%, and 7% higher risk of mortality for localized, regional, and distant stage, respectively, was observed among individuals with Medicaid vs privately insured people with the same stage of disease. An 88%, 59%, and 35% higher risk of mortality for localized, regional, and distant stage, respectively, was seen in uninsured people vs privately insured people. Findings revealed the presence of differences in survival by the type of insurance that people with HCC have at the time of diagnosis.